biological source
rabbit
conjugate
unconjugated
antibody form
affinity isolated antibody
antibody product type
primary antibodies
clone
polyclonal
form
buffered aqueous solution
mol wt
~250 kDa
species reactivity
mouse, human
enhanced validation
recombinant expression
Learn more about Antibody Enhanced Validation
concentration
~1.0 mg/mL
technique(s)
immunohistochemistry: 10-20 μg/mL using differentiated C2C12 myoblasts, immunoprecipitation (IP): 5-10 μg using HEK-293T cells over-expressing human dysferlin, western blot: 0.5-1.0 μg/mL using HEK-293T cells over-expressing human dysferlin
UniProt accession no.
shipped in
dry ice
storage temp.
−20°C
target post-translational modification
unmodified
Gene Information
human ... DYSF(8291)
mouse ... Dysf(26903)
正在寻找类似产品? 访问 产品对比指南
General description
Dysferlin is a transmembrane protein that belongs to the ferlin-1 family. It is mostly expressed in the early stages of human development. Dysferlin comprises a C-terminal transmembrane domain and a long N-terminal cytoplasmic region. Dysferlin gene is mapped to 2p13.2.
Immunogen
synthetic peptide corresponding to an internal sequence of human dysferlin (GeneID: 8291), conjugated to KLH.
Application
Anti-Dysferlin antibody produced in rabbit may be used in:
- immunoblotting
- immunoprecipitation
- immunofluorescence
Biochem/physiol Actions
Anti-Dysferlin specifically recognizes human and mouse dysferlin.
Dysferlin localizes in the membrane and aids trafficking along with caveolin protein. The N-terminal region of dysferlin is essential for vesicular traffic and membrane fusion. Mutations in the dysferlin gene is implicated in the limb-girdle muscle dystrophy type 2B (LGMD2B), an autosomal recessive disorder and the related Miyoshi myopathy. It has been suggested to play a role in membrane fusion and repair processes, such as the ability to reseal the sarcolemma upon muscle injury. The integral membrane proteins caveolin-1 and -3 have been shown to regulate the endocytosis of dysferlin.4. Mutations in the caveolin-3 and 1 results in mistargeting and redistribution of dysferlin from the plasma membrane to the Golgi complex.
Physical form
solution in 0.01 M phosphate buffered saline, pH 7.4, containing 15 mM sodium azide.
Preparation Note
For continuous use, store at 2-8 °C for up to one month. For extended storage, freeze in working aliquots. Repeated freezing and thawing, or storage in “frost-free” freezers,is not recommended. If slight turbidity occurs upon prolongedstorage, clarify the solution by centrifugation before use. Working dilutions should be discarded if not used within 12 hours.
Disclaimer
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
未找到合适的产品?
试试我们的产品选型工具.
存储类别
10 - Combustible liquids
flash_point_f
Not applicable
flash_point_c
Not applicable
法规信息
新产品
此项目有
Caveolin regulates endocytosis of the muscle repair protein, dysferlin
Hernandez-Deviez DJ, et al.
Test, 283(10), 6476-6488 (2008)
Genetic basis of limb-girdle muscular dystrophies: the 2014 update
Nigro V and Savarese M
Acta Myologica : Myopathies and Cardiomyopathies : Official Journal of the Mediterranean Society of Myology / Edited by the Gaetano Conte Academy for the Study of Striated Muscle Diseases, 33(1), 1-1 (2014)
S H Laval et al.
Neuropathology and applied neurobiology, 30(2), 91-105 (2004-03-27)
The limb-girdle muscular dystrophies are a diverse group of muscle-wasting disorders characteristically affecting the large muscles of the pelvic and shoulder girdles. Molecular genetic analyses have demonstrated causative mutations in the genes encoding a disparate collection of proteins involved in
Dimple Bansal et al.
Nature, 423(6936), 168-172 (2003-05-09)
Muscular dystrophy includes a diverse group of inherited muscle diseases characterized by wasting and weakness of skeletal muscle. Mutations in dysferlin are linked to two clinically distinct muscle diseases, limb-girdle muscular dystrophy type 2B and Miyoshi myopathy, but the mechanism
Louise Glover et al.
Traffic (Copenhagen, Denmark), 8(7), 785-794 (2007-06-06)
The muscular dystrophies are a heterogeneous group of inherited disorders, defined by progressive muscle weakness and atrophy. Following the discovery of dystrophin, remarkable progress has been made in defining the molecular properties of proteins involved in the various dystrophies. This
相关内容
Instructions
我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持